Carregant...

Prevention of breast cancer using selective oestrogen receptor modulators (SERMs)

Placebo controlled trials in over 25,000 women showed that tamoxifen reduced breast cancer risk by about 40% and osteoporotic fracture risk by about 32%. Similarly placebo controlled trials in nearly 18,000 women showed that raloxifene reduced breast cancer risk by 44–72% and osteoporotic fractures...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Powles, Trevor J
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2006
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1779496/
https://ncbi.nlm.nih.gov/pubmed/17049068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr1601
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!